Total Payments
$2.7M
2024 Payments
$430,559
Companies
20
Transactions
3,332
Payment Breakdown by Category
Other$2.1M (78.1%)
Travel$353,204 (13.3%)
Consulting$160,512 (6.0%)
Food & Beverage$54,947 (2.1%)
Research$13,337 (0.5%)
Education$180.56 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.1M | 915 | 77.6% |
| Travel and Lodging | $353,204 | 1,365 | 13.3% |
| Consulting Fee | $160,512 | 72 | 6.0% |
| Food and Beverage | $54,947 | 943 | 2.1% |
| Unspecified | $13,337 | 1 | 0.5% |
| Honoraria | $11,742 | 25 | 0.4% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,875 | 1 | 0.1% |
| Education | $180.56 | 10 | 0.0% |
Payments by Type
General
$2.6M
3,331 transactions
Research
$13,337
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $696,119 | 822 | $0 (2024) |
| ABBVIE INC. | $534,080 | 464 | $0 (2024) |
| Allergan, Inc. | $372,738 | 753 | $0 (2021) |
| ITI, Inc. | $287,173 | 264 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $208,542 | 324 | $0 (2020) |
| Merck Sharp & Dohme LLC | $117,605 | 181 | $0 (2022) |
| Axsome Therapeutics, Inc. | $98,781 | 118 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $91,066 | 73 | $0 (2024) |
| Alkermes, Inc. | $87,521 | 100 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $60,841 | 92 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $430,559 | 357 | ABBVIE INC. ($140,230) |
| 2023 | $391,379 | 341 | AbbVie Inc. ($153,900) |
| 2022 | $367,727 | 362 | ABBVIE INC. ($142,782) |
| 2021 | $254,962 | 285 | AbbVie Inc. ($97,168) |
| 2020 | $182,266 | 246 | Allergan, Inc. ($94,975) |
| 2019 | $259,622 | 429 | Otsuka America Pharmaceutical, Inc. ($104,715) |
| 2018 | $370,560 | 685 | Otsuka America Pharmaceutical, Inc. ($111,328) |
| 2017 | $399,703 | 627 | Otsuka America Pharmaceutical, Inc. ($128,756) |
All Payment Transactions
3,332 individual payment records from CMS Open Payments — Page 1 of 134
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,095.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,095.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,095.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,925.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,060.00 | General |
| Category: CNS | ||||||
| 12/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,620.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $791.95 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $251.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $133.40 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,400.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | In-kind items and services | $355.26 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $114.30 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $672.92 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $455.04 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $136.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,095.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,925.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,808.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,320.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | In-kind items and services | $216.49 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: CNS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 1, OPEN-LABEL, SINGLE-DOSE PHARMACOKINETIC STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE | Eli Lilly and Company | $13,337 | 1 |
About Dr. David Scheiderer, M.D
Dr. David Scheiderer, M.D is a Psychiatry healthcare provider based in Roanoke, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1699978221.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Scheiderer, M.D has received a total of $2.7M in payments from pharmaceutical and medical device companies, with $430,559 received in 2024. These payments were reported across 3,332 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2.1M).
Ad
Practice Information
- Specialty Psychiatry
- Location Roanoke, VA
- Active Since 06/10/2007
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1699978221
Products in Payments
- VRAYLAR (Drug) $896,586
- REXULTI (Drug) $688,460
- CAPLYTA (Drug) $378,240
- LATUDA (Drug) $208,166
- BELSOMRA (Drug) $117,605
- Auvelity (Drug) $89,026
- LYBALVI (Drug) $87,190
- Trintellix (Drug) $73,734
- Dayvigo (Drug) $32,900
- SECUADO (Drug) $12,214
- NAMZARIC (Drug) $10,027
- Sunosi (Drug) $9,755
- FANAPT (Drug) $8,571
- QUVIVIQ (Drug) $4,606
- ABILIFY MAINTENA (Drug) $1,322
- APTIOM (Drug) $376.37
- ARISTADA (Drug) $330.61
- VIIBRYD (Drug) $204.62
- Entyvio (Biological) $196.20
- TRINTELLIX (Drug) $91.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Roanoke
Mr. Ralph Mckenzie, D.o, D.O
Psychiatry — Payments: $137,557
Psychiatry $137,557
Anita Kablinger, M.d, M.D
Psychiatry — Payments: $90,108
Psychiatry $90,108
Dr. Robert Murdock, M.d, M.D
Psychiatry — Payments: $5,262
Psychiatry $5,262
Dr. Khoa Tran, Md, MD
Psychiatry — Payments: $3,810
Psychiatry $3,810
Roopa Sethi, M.d, M.D
Psychiatry — Payments: $2,317
Psychiatry $2,317
Dr. Richard Linsk, Md, Phd, MD, PHD
Psychiatry — Payments: $2,212
Psychiatry $2,212